Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases

被引：15
|
作者：
Ostrov, Barbara E. [1 ]
机构：
[1] Penn State Hershey Childrens Hosp, Dept Pediat Pediat Rheumatol & Rheumatol, Hershey, PA 17033 USA
来源：
IMMUNOLOGICAL INVESTIGATIONS | 2015年 / 44卷 / 08期
关键词：
Autoimmune diseases; autoinflammatory diseases; biologic therapy; immunotherapy; JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; PERIODIC SYNDROME; CROHNS-DISEASE; MONOCLONAL-ANTIBODIES; OPEN-LABEL; THERAPY; INFLIXIMAB; INTERLEUKIN-2;
D O I：
10.3109/08820139.2015.1093912
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In recent decades, innovative strategies to treat patients with inflammatory, immunologically based diseases have advanced in concert with our increased understanding of molecular immunology. Recognition of the spectrum and pathophysiology of autoimmune and autoinflammatory disorders has allowed for the development of cutting-edge therapies for such patients. In this review, key immunotherapeutic approaches for treating inflammatory autoimmune disorders, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), as well as genetic autoinflammatory diseases, such as cryopyrin associated periodic syndromes, are addressed. Indications, risks and additional considerations in the use of these agents are reviewed.
引用
收藏
页码：777 / 802
页数：26
相关论文
共 50 条
  • [1] Biologic agents in autoimmune diseases
    Keystone, EC
    Strand, V
    [J]. JOURNAL OF RHEUMATOLOGY, 1996, 23 (04) : 743 - 746
  • [2] Interplay of Anti-Viral Vaccines with Biologic Agents and Immunomodulators in Individuals with Autoimmune and Autoinflammatory Diseases
    Ostrov, Barbara E.
    Amsterdam, Daniel
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2021, 50 (07) : 833 - 856
  • [3] BIOLOGIC AGENTS IN AUTOIMMUNE RHEUMATIC DISEASES AND BONE HEALTH
    Athanassiou, L.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S102 - S102
  • [4] Biologic modulators in allergic and autoinflammatory diseases
    Broderick, Lori
    Tourangeau, Louanne M.
    Kavanaugh, Arthur
    Wasserman, Stephen I.
    [J]. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (04) : 355 - 360
  • [5] Bridging autoinflammatory and autoimmune diseases
    El-Shebiny, Emad M.
    Zahran, Enas S.
    Shoeib, Sabry A.
    Habib, Eman S.
    [J]. EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2021, 33 (01):
  • [6] Bridging autoinflammatory and autoimmune diseases
    Emad M. El-Shebiny
    Enas S. Zahran
    Sabry A. Shoeib
    Eman S. Habib
    [J]. The Egyptian Journal of Internal Medicine, 2021, 33
  • [7] Taming the TCR: Antigen-Specific Immunotherapeutic Agents for Autoimmune Diseases
    Sauer, Evan L.
    Cloake, Nancy C.
    Greer, Judith M.
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2015, 34 (06) : 460 - 485
  • [8] Immunotherapeutic Targeting in Autoimmune Diseases
    Janikashvili, Nona
    Samson, Maxime
    Magen, Eli
    Chikovani, Tinatin
    [J]. MEDIATORS OF INFLAMMATION, 2016, 2016
  • [9] Musculoskeletal manifestations and autoimmune diseases related to new biologic agents
    Haraoui, B
    Keystone, E
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (01) : 96 - 100
  • [10] Canakinumab in autoimmune and autoinflammatory rheumatic diseases
    Kadavath, Sabeeda
    Efthimiou, Petros
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (01): : 27 - 35
12345